CBmed

CBmed operates as a public-private partnership focused on advancing precision medicine by developing and validating minimally invasive biomarkers. It leverages global academic and industry partnerships to deliver high-quality applied biomedical research solutions. The company integrates cutting-edge technologies—including multiomics data analysis—and collaborates with leading biobanks such as Biobank Graz to support translational medicine from discovery through clinical application. Its primary impact lies in enabling more personalized diagnosis, therapy monitoring, and patient care rather than direct drug development or commercialization of therapeutics.